NO20013099D0 - Kombinasjonskjemoterapi - Google Patents

Kombinasjonskjemoterapi

Info

Publication number: NO20013099D0
Authority: NO; Norway
Prior art keywords: combination chemotherapy; chemotherapy; combination
Prior art date: 1998-12-22

Application number

NO20013099A

Other languages

English (en)

Other versions

NO20013099L (no

Inventor

Richard Carleton Gowan

Judith Sebolt-Leopold

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-12-22

Filing date

2001-06-21

Publication date

2001-06-21

2001-06-21 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

2001-06-21 Publication of NO20013099D0 publication Critical patent/NO20013099D0/no

2001-08-20 Publication of NO20013099L publication Critical patent/NO20013099L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Seasonings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20013099A 1998-12-22 2001-06-21 Kombinasjonskjemoterapi NO20013099L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US11329198P	1998-12-22	1998-12-22
US16478899P	1999-11-10	1999-11-10
PCT/US1999/030485 WO2000037141A1 (en)	1998-12-22	1999-12-21	Combination chemotherapy

Publications (2)

Publication Number	Publication Date
NO20013099D0 true NO20013099D0 (no)	2001-06-21
NO20013099L NO20013099L (no)	2001-08-20

Family

ID=26810891

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20013099A NO20013099L (no)	1998-12-22	2001-06-21	Kombinasjonskjemoterapi

Country Status (31)

Country	Link
EP (1)	EP1140291B1 (no)
JP (1)	JP2002532570A (no)
KR (1)	KR20010099877A (no)
CN (1)	CN1333698A (no)
AP (1)	AP2001002175A0 (no)
AT (1)	ATE310567T1 (no)
AU (1)	AU2203900A (no)
BG (1)	BG105715A (no)
BR (1)	BR9916839A (no)
CA (1)	CA2352326A1 (no)
CZ (1)	CZ20012139A3 (no)
DE (1)	DE69928568T2 (no)
EA (1)	EA200100687A1 (no)
EE (1)	EE200100339A (no)
ES (1)	ES2253928T3 (no)
GE (1)	GEP20043172B (no)
HK (1)	HK1042057A1 (no)
HR (1)	HRP20010473A2 (no)
HU (1)	HUP0104844A3 (no)
ID (1)	ID30250A (no)
IL (1)	IL143939A0 (no)
IS (1)	IS5969A (no)
MA (1)	MA26768A1 (no)
NO (1)	NO20013099L (no)
NZ (1)	NZ512859A (no)
OA (1)	OA11733A (no)
PL (1)	PL348326A1 (no)
SK (1)	SK8712001A3 (no)
TR (1)	TR200101871T2 (no)
WO (1)	WO2000037141A1 (no)
YU (1)	YU45401A (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU230251B1 (hu)	2000-07-19	2015-11-30	Warner-Lambert Co.	4-Jód-fenil-amino-benzhidroxámsav-észter-származékok és ezeket tartalmazó gyógyászati készítmények
US20020054869A1 (en)	2000-09-01	2002-05-09	Han-Mo Koo	Inhibition of mitogen-activated protein kinase (MAPK) pathway: a selective therapeutic strategy against melanoma
WO2002076496A1 (en) *	2001-03-22	2002-10-03	Van Andel Institute	Anthrax lethal factor inhibits tumor growth and angiogenesis
IL149462A0 (en)	2001-05-09	2002-11-10	Warner Lambert Co	Method of treating or inhibiting neutrophil chemotaxis by administering a mek inhibitor
CZ20022216A3 (cs) *	2001-07-02	2003-05-14	Warner-Lambert Company	Kombinační chemoterapie
AU2004279721A1 (en) *	2003-10-08	2005-04-21	Teijin Pharma Limited	Process for producing aminopyrrolidine derivative and intermediate compound
NZ546011A (en)	2003-10-21	2009-09-25	Warner Lambert Co	Polymorphic form of N-[(R)-2,3-dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide
PT1802579E (pt) *	2004-10-20	2014-02-17	Merck Serono Sa	Derivados da 3-arilaminopiridina
CN1807413B (zh) *	2005-09-28	2010-05-05	中国医学科学院医药生物技术研究所	咔唑磺酰胺衍生物及其制备方法
SI1934174T1 (sl)	2005-10-07	2011-08-31	Exelixis Inc	Inhibitorji MEK in postopki za njihovo uporabo
JP5527972B2 (ja)	2005-11-11	2014-06-25	エテルナツェンタリスゲゼルシャフトミットベシュレンクテルハフツング	新規のピリドピラジン及び前記ピリドピラジンをキナーゼのモジュレーターとして用いる使用
US8217042B2 (en)	2005-11-11	2012-07-10	Zentaris Gmbh	Pyridopyrazines and their use as modulators of kinases
EP1790342A1 (de)	2005-11-11	2007-05-30	Zentaris GmbH	Pyridopyrazin-Derivate und deren Verwendung als Modulatoren der Signaltransduktionswege
TR201900306T4 (tr)	2006-12-14	2019-02-21	Exelixis Inc	Mek inhibitörlerini kullanma yöntemleri.
WO2010068738A1 (en)	2008-12-10	2010-06-17	Dana-Farber Cancer Institute, Inc.	Mek mutations conferring resistance to mek inhibitors
CA2789696C (en)	2010-02-25	2017-11-07	Dana-Farber Cancer Institute, Inc.	Braf mutations conferring resistance to braf inhibitors
CN103038364A (zh)	2010-03-09	2013-04-10	达纳－法伯癌症研究所公司	诊断和治疗具有或发展对于第一种癌症治疗的抗性的患者中的癌症的方法
CN103301096B (zh) *	2012-03-14	2015-05-06	中国中化股份有限公司	取代二苯胺类化合物作为制备抗肿瘤药物的应用
WO2013169858A1 (en)	2012-05-08	2013-11-14	The Broad Institute, Inc.	Diagnostic and treatment methods in patients having or at risk of developing resistance to cancer therapy
BR112015008113B1 (pt)	2012-10-12	2022-05-24	Exelixis, Inc.	Novo processo para preparar compostos para uso no tratamento de câncer
ES2703208T3 (es) *	2013-02-27	2019-03-07	Daiichi Sankyo Co Ltd	Método de predicción de la sensibilidad a un compuesto que inhibe la vía de transducción de señales de MAPK
CN105384754B (zh) *	2014-09-02	2018-04-20	上海科州药物研发有限公司	作为蛋白激酶抑制剂的杂环类化合物及其制备方法和用途
CN111909053B (zh) *	2020-08-06	2022-12-06	湖北省生物农药工程研究中心	基于二芳胺单元的酰胺类衍生物及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL112248A0 (en) *	1994-01-25	1995-03-30	Warner Lambert Co	Tricyclic heteroaromatic compounds and pharmaceutical compositions containing them
AU2092597A (en) *	1996-03-07	1997-09-22	Novartis Ag	Antiproliferative combinations, containing raf-targeted oligonucleotides and chemotherapeutic compounds
US6251943B1 (en) *	1997-02-28	2001-06-26	Warner-Lambert Company	Method of treating or preventing septic shock by administering a MEK inhibitor
EP0988376A2 (en) *	1997-03-21	2000-03-29	The Board Of Regents, The University Of Texas System	Noey2 gene compositions and methods of use
US6002008A (en) *	1997-04-03	1999-12-14	American Cyanamid Company	Substituted 3-cyano quinolines
US6040321A (en) *	1997-11-12	2000-03-21	Bristol-Myers Squibb Company	Aminothiazole inhibitors of cyclin dependent kinases
US5959097A (en) *	1998-11-20	1999-09-28	Isis Pharmaceuticals, Inc.	Antisense modulation of MEK2 expression

1999
- 1999-12-21 AU AU22039/00A patent/AU2203900A/en not_active Abandoned
- 1999-12-21 CA CA002352326A patent/CA2352326A1/en not_active Abandoned
- 1999-12-21 ID IDW00200101616A patent/ID30250A/id unknown
- 1999-12-21 BR BR9916839-1A patent/BR9916839A/pt not_active Application Discontinuation
- 1999-12-21 DE DE69928568T patent/DE69928568T2/de not_active Expired - Fee Related
- 1999-12-21 KR KR1020017007874A patent/KR20010099877A/ko not_active Withdrawn
- 1999-12-21 YU YU45401A patent/YU45401A/sh unknown
- 1999-12-21 GE GEAP19996007A patent/GEP20043172B/en unknown
- 1999-12-21 SK SK871-2001A patent/SK8712001A3/sk unknown
- 1999-12-21 EE EEP200100339A patent/EE200100339A/xx unknown
- 1999-12-21 HU HU0104844A patent/HUP0104844A3/hu unknown
- 1999-12-21 EA EA200100687A patent/EA200100687A1/ru unknown
- 1999-12-21 TR TR2001/01871T patent/TR200101871T2/xx unknown
- 1999-12-21 AP APAP/P/2001/002175A patent/AP2001002175A0/en unknown
- 1999-12-21 ES ES99966523T patent/ES2253928T3/es not_active Expired - Lifetime
- 1999-12-21 AT AT99966523T patent/ATE310567T1/de not_active IP Right Cessation
- 1999-12-21 CZ CZ20012139A patent/CZ20012139A3/cs unknown
- 1999-12-21 PL PL99348326A patent/PL348326A1/xx not_active Application Discontinuation
- 1999-12-21 CN CN99815040A patent/CN1333698A/zh active Pending
- 1999-12-21 WO PCT/US1999/030485 patent/WO2000037141A1/en not_active Ceased
- 1999-12-21 HR HR20010473A patent/HRP20010473A2/hr not_active Application Discontinuation
- 1999-12-21 JP JP2000589248A patent/JP2002532570A/ja active Pending
- 1999-12-21 IL IL14393999A patent/IL143939A0/xx unknown
- 1999-12-21 HK HK02103397.1A patent/HK1042057A1/zh unknown
- 1999-12-21 OA OA1200100161A patent/OA11733A/en unknown
- 1999-12-21 EP EP99966523A patent/EP1140291B1/en not_active Expired - Lifetime
- 1999-12-21 NZ NZ512859A patent/NZ512859A/en unknown
2001
- 2001-06-14 IS IS5969A patent/IS5969A/is unknown
- 2001-06-21 NO NO20013099A patent/NO20013099L/no not_active Application Discontinuation
- 2001-07-18 BG BG105715A patent/BG105715A/xx unknown
- 2001-07-19 MA MA26275A patent/MA26768A1/fr unknown

Also Published As

Publication number	Publication date
KR20010099877A (ko)	2001-11-09
MA26768A1 (fr)	2004-12-20
HUP0104844A3 (en)	2003-05-28
EP1140291A1 (en)	2001-10-10
GEP20043172B (en)	2004-02-25
HUP0104844A2 (en)	2002-06-29
BG105715A (en)	2002-04-30
ES2253928T3 (es)	2006-06-01
IS5969A (is)	2001-06-14
CA2352326A1 (en)	2000-06-29
HK1042057A1 (zh)	2002-08-02
NZ512859A (en)	2004-06-25
DE69928568D1 (de)	2005-12-29
SK8712001A3 (en)	2002-02-05
NO20013099L (no)	2001-08-20
TR200101871T2 (tr)	2001-10-22
OA11733A (en)	2005-05-12
EP1140291B1 (en)	2005-11-23
IL143939A0 (en)	2002-04-21
EE200100339A (et)	2002-10-15
WO2000037141A9 (en)	2000-12-07
AP2001002175A0 (en)	2001-06-21
BR9916839A (pt)	2001-10-09
YU45401A (sh)	2004-07-15
WO2000037141A1 (en)	2000-06-29
ATE310567T1 (de)	2005-12-15
CZ20012139A3 (cs)	2002-01-16
EA200100687A1 (ru)	2001-12-24
DE69928568T2 (de)	2006-07-27
AU2203900A (en)	2000-07-12
HRP20010473A2 (en)	2002-08-31
PL348326A1 (en)	2002-05-20
JP2002532570A (ja)	2002-10-02
CN1333698A (zh)	2002-01-30
ID30250A (id)	2001-11-15

Publication	Publication Date	Title
DE69829040D1 (de)	2005-03-24	Elektroplattierungschemie
DE69936443D1 (de)	2007-08-16	Bedienungspersoneingagabevorrichtung
DE69933567D1 (de)	2006-11-23	Sigmidoskop
DE69924816D1 (de)	2005-05-25	Fluidumverdichter
DE69904595D1 (de)	2003-01-30	Betacarbolinverbindungen
DE69940840D1 (de)	2009-06-18	Vollkegelzerstäuberdüse
DE69921320D1 (de)	2004-11-25	Turbinenstatorschaufel
DE69936094D1 (de)	2007-06-28	Banknotenabtaster
FI980536A7 (fi)	1999-09-10	Kokoonpanolinja
ID30250A (id)	2001-11-15	Kemoterapi kombinasi
ID24739A (id)	2000-08-03	Senyawa-senyawa
ID24221A (id)	2000-07-13	Tempat patrum
DE69937642D1 (de)	2008-01-10	Trimaranstruktur
DE69902762D1 (de)	2002-10-10	Riser-spannanordnung
DE59911683D1 (de)	2005-04-07	Fahrzeugschliessanlage
DE69916308D1 (de)	2004-05-13	Hydroboronationsverfahren
DK1124809T3 (da)	2004-07-19	Benzoylpyridaziner
DE69827358D1 (de)	2004-12-09	Weglenkungsverfahren
DE69933674D1 (de)	2006-11-30	Nagigationsvorrichtung
DE59807217D1 (de)	2003-03-20	Nadellager
DE69901739D1 (de)	2002-07-18	Walzenstuhlgehaüse
DE69939197D1 (de)	2008-09-11	Münzschiebespielgerät
ATA32198A (de)	2000-01-15	Beschlag
DE59903771D1 (de)	2003-01-23	Hydro-transformator
DK1097334T3 (da)	2004-05-17	Rörbur

Legal Events

Date	Code	Title	Description
2006-07-31	FC2A	Withdrawal, rejection or dismissal of laid open patent application